Assessment of Pharmacovigilance Across University Hospitals in Morocco
The assessment revealed a subgroup of centers with well-established AE signal detection and causality assessment abilities, which could play a leading role in the country. After the site assessment, our collaborative approach of bringing together focal points to identify next steps and generate buy-in helped to formalize pharmacovigilance across centers.
Authors
- Imad Cherkaoui (ORCID: https://orcid.org/0000-0001-9177-229X)
- Ismail Talibi
- Latifa Aït Moussa (ORCID: https://orcid.org/0000-0001-9016-8445)
- Ghita Benabdallah (ORCID: https://orcid.org/0000-0002-2986-6401)
- Omar Salman (ORCID: https://orcid.org/0000-0003-4797-6927)
- Anna Shaum (ORCID: https://orcid.org/0000-0001-7088-5754)
- Rachida Soulaymani Bencheikh (ORCID: https://orcid.org/0000-0002-3764-3523)
- Houda Sefiani (ORCID: https://orcid.org/0000-0003-2938-3183)
- Hind Hamzaoui
- Seth Ferrey
Institutions
- Centers for Disease Control and Prevention (US)
- Ministère de la Santé (MA)
- Instituto Superior da Maia (PT)
Publication Details
- Journal
- Drug Safety
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1007/s40264-025-01517-w
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.31
Funders
- Centers for Disease Control and Prevention